Will you have Dacryoadenitis acquired with Afinitor - from FDA reports

Summary

Dacryoadenitis acquired is reported only by a few people who take Afinitor. We study 27,445 people who have side effects while taking Afinitor from FDA. Among them, 1 have Dacryoadenitis acquired. Find out below who they are, when they have Dacryoadenitis acquired and more.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Dacryoadenitis acquired are also considered in the study.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. (latest outcomes from Afinitor 27,509 users)

What is Dacryoadenitis acquired?

Dacryoadenitis acquired (inflammation of the lacrimal glands acquired) has been reported by people with high blood pressure, hyperthyroidism, hepatitis c, rheumatoid arthritis, multiple sclerosis (latest reports from 35 Dacryoadenitis acquired patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 10, 2019

27,445 people reported to have side effects when taking Afinitor.
Among them, 1 person (0.0%) has Dacryoadenitis acquired


Number of reports submitted per year:

Could Afinitor cause Dacryoadenitis acquired?

Gender of people who have Dacryoadenitis acquired when taking Afinitor *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Dacryoadenitis acquired when taking Afinitor *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 100.00%

Top co-used drugs for these people *:

  1. Remicade: 1 person, 100.00%
  2. Omeprazole: 1 person, 100.00%
  3. Lasix: 1 person, 100.00%
  4. Gabapentin: 1 person, 100.00%
  5. Fosamax: 1 person, 100.00%

Top other side effects for these people *:

  1. Lung Disorder (lung disease): 1 person, 100.00%
  2. Breathing Difficulty: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.


Do you have Dacryoadenitis acquired while taking Afinitor?

You are not alone:




Related studies

Drugs that are associated with Dacryoadenitis acquired
Dacryoadenitis acquired (27 drugs)
Could your condition cause Dacryoadenitis acquired
Dacryoadenitis acquired (21 conditions)
Afinitor side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Afinitor
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Afinitor with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Afinitor and have Dacryoadenitis acquired



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.